德英 (4911)
德英 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$11.44M, down 56.0% from a year earlier. EPS over the last four quarters totals NT$1.32.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2011-03-21
- Founded
- 2002-08-06
- Paid-in capital
- NT$688.17M
- Common shares issued
- 68,817,133
- Legal name
- 德英生物科技股份有限公司
- Website
- https://www.geherbs.com.tw
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$11.44M | -1.1% | -56.0% |
| 2026-08 | NT$11.56M | +2.4% | -55.3% |
Year to date: -57.9% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.10 |
| 2026 Q1 | 0.23 |
| 2025 Q4 | 0.42 |
| 2025 Q3 | 0.57 |
| 2025 Q2 | 0.57 |
| 2025 Q1 | 0.62 |
| 2024 Q4 | 0.53 |
| 2024 Q3 | 0.42 |
Last four quarters: NT$1.32
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 1.17 | 0.80 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 1,139 | 0.2% |
| 1,000–5,000 shares | 1,517 | 4.6% |
| 5,001–10,000 shares | 292 | 2.9% |
| 10,001–15,000 shares | 178 | 3.1% |
| 15,001–20,000 shares | 74 | 1.9% |
| 20,001–30,000 shares | 76 | 2.7% |
| 30,001–40,000 shares | 42 | 2.1% |
| 40,001–50,000 shares | 37 | 2.4% |
| 50,001–100,000 shares | 65 | 6.5% |
| 100,001–200,000 shares | 36 | 7.0% |
| 200,001–400,000 shares | 21 | 8.3% |
| 400,001–600,000 shares | 6 | 4.4% |
| 600,001–800,000 shares | 3 | 3.0% |
| 800,001–1,000,000 shares | 2 | 2.7% |
| 1,000,001+ shares | 9 | 48.0% |
TDCC data for 2026-10-16: 9 holders own more than 1,000 lots (48.0% of shares), and 1,139 hold less than one lot (0.2%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 0 | 0 | 0 | 0 |
| 2026-10-16 | -1 | 0 | 0 | -1 |
| 2026-10-15 | 0 | 0 | 0 | 0 |
| 2026-10-14 | 1 | 0 | 0 | 1 |
| 2026-10-13 | -4 | 0 | 0 | -4 |
| 2026-10-12 | -1 | 0 | 0 | -1 |
| 2026-10-06 | 0 | 0 | 0 | 0 |
| 2026-10-05 | 0 | 0 | 0 | 0 |
| 2026-10-02 | 1 | 0 | 0 | 1 |
| 2026-10-01 | 1 | 0 | 0 | 1 |
| 2026-09-29 | 0 | 0 | 0 | 0 |
| 2026-09-18 | 6 | 0 | 0 | 6 |
| 2026-09-17 | 2 | 0 | 0 | 2 |
| 2026-09-16 | 3 | 0 | 0 | 3 |
| 2026-09-14 | 3 | 0 | 0 | 3 |
| 2026-09-11 | 1 | 0 | 0 | 1 |
| 2026-09-10 | -1 | 0 | 0 | -1 |
| 2026-09-09 | 3 | 0 | 0 | 3 |
| 2026-09-08 | 0 | 0 | -11 | -11 |
| 2026-09-07 | -1 | 0 | 0 | -1 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 2 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$27.45 (2026-10-19); 52-week range NT$26.80–50.20.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.